Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Clin Oncol (R Coll Radiol) ; 35(6): e362-e375, 2023 06.
Article in English | MEDLINE | ID: mdl-36967312

ABSTRACT

AIMS: Understanding the correlations between underlying medical and personal characteristics of a patient with cancer and the risk of lung metastasis may improve clinical management and outcomes. We used machine learning methodologies to predict the risk of lung metastasis using readily available predictors. MATERIALS AND METHODS: We retrospectively analysed a cohort of 11 164 oncological patients, with clinical records gathered between 2000 and 2020. The input data consisted of 94 parameters, including age, body mass index (BMI), sex, social history, 81 primary cancer types, underlying lung disease and diabetes mellitus. The strongest underlying predictors were discovered with the analysis of the highest performing method among four distinct machine learning methods. RESULTS: Lung metastasis was present in 958 of 11 164 oncological patients. The median age and BMI of the study population were 63 (±19) and 25.12 (±5.66), respectively. The random forest method had the most robust performance among the machine learning methods. Feature importance analysis revealed high BMI as the strongest predictor. Advanced age, smoking, male gender, alcohol dependence, chronic obstructive pulmonary disease and diabetes were also strongly associated with lung metastasis. Among primary cancers, melanoma and renal cancer had the strongest correlation. CONCLUSIONS: Using a machine learning-based approach, we revealed new correlations between personal and medical characteristics of patients with cancer and lung metastasis. This study highlights the previously unknown impact of predictors such as obesity, advanced age and underlying lung disease on the occurrence of lung metastasis. This prediction model can assist physicians with preventive risk factor control and treatment strategies.


Subject(s)
Diabetes Mellitus , Lung Neoplasms , Humans , Male , Retrospective Studies , Risk Factors , Diabetes Mellitus/epidemiology
2.
Cancer Radiother ; 27(1): 31-41, 2023 Feb.
Article in English | MEDLINE | ID: mdl-35965243

ABSTRACT

PURPOSE: To compare three different radiotherapy devices able to perform pulmonary stereotactic radiotherapy: CyberKnife® (CK), Helical Tomotherapy® (HT), and volumetric modulated arc therapy (VMAT). This study aims to define the patients' outcome in terms of SBRT efficacy and toxicities depending of the device choice. MATERIALS AND METHODS: We retrospectively analyzed the clinical, radiological, and dosimetric data of patients treated with lung SBRT between 2016 and 2020 at Lausanne University Hospital, using the Chi2 test for proportions, the t-test for means comparisons, the Kaplan-Meier method for survival, and the Log-rank test and Cox-regression for intergroups comparisons. RESULTS: We identified 111 patients treated by either CK (59.9%), VMAT (38.0%), or HT (2.1%). Compared to other techniques, CK treated comparable gross tumor volume (GTV; 2.1 vs. 1.4cm3, P=0.84) with smaller planning treatment volume (PTV; 12.3 vs. 21.9cm3, P=0.013) and lower V5 (13.5 vs. 19.9cm3, P=0.002). Local control rates at 2years were not different whatever the irradiation device, respectively of 96.2% (range, 90.8-100) and 98.1% (range, 94.4-100), P=0.68. Toxicity incidence significantly increased with V5 value>17.2% (56.0 vs. 77.4%, P=0.021). CONCLUSION: Compared to other SBRT techniques, CK treatments permitted to treat comparable GTV with reduced PTV and V5. Toxicity incidence was less frequent when reducing the V5. CK is particularly attractive in case of multiple courses of lung SBRT or lung reirradiation.


Subject(s)
Lung Neoplasms , Radiosurgery , Radiotherapy, Intensity-Modulated , Humans , Radiosurgery/adverse effects , Radiosurgery/methods , Retrospective Studies , Lung Neoplasms/pathology , Radiotherapy, Intensity-Modulated/adverse effects , Radiotherapy, Intensity-Modulated/methods , Radiotherapy Planning, Computer-Assisted/methods , Radiotherapy Dosage , Lung
3.
BMC Infect Dis ; 20(1): 527, 2020 Jul 22.
Article in English | MEDLINE | ID: mdl-32698804

ABSTRACT

BACKGROUND: Conidiobolus spp. (mainly C. coronatus) are the causal agents of rhino-facial conidiobolomycosis, a limited soft tissue infection, which is essentially observed in immunocompetent individuals from tropical areas. Rare cases of invasive conidiobolomycosis due to C. coronatus or other species (C.incongruus, C.lamprauges) have been reported in immunocompromised patients. We report here the first case of invasive pulmonary fungal infection due to Conidiobolus pachyzygosporus in a Swiss patient with onco-haematologic malignancy. CASE PRESENTATION: A 71 year-old female was admitted in a Swiss hospital for induction chemotherapy of acute myeloid leukemia. A chest CT performed during the neutropenic phase identified three well-circumscribed lung lesions consistent with invasive fungal infection, along with a positive 1,3-beta-d-glucan assay in serum. A transbronchial biopsy of the lung lesions revealed large occasionally septate hyphae. A Conidiobolus spp. was detected by direct 18S rDNA in the tissue biopsy and subsequently identified at species level as C. pachyzygosporus by 28S rDNA sequencing. The infection was cured after isavuconazole therapy, recovery of the immune system and surgical resection of lung lesions. CONCLUSIONS: This is the first description of C. pachyzygosporus as human pathogen and second case report of invasive conidiobolomycosis from a European country.


Subject(s)
Conidiobolus/genetics , Leukemia, Myeloid, Acute/complications , Lung Diseases, Fungal/complications , Lung Diseases, Fungal/diagnosis , Zygomycosis/complications , Zygomycosis/diagnosis , Aged , Antifungal Agents/therapeutic use , Biopsy , Conidiobolus/isolation & purification , DNA, Fungal/genetics , DNA, Ribosomal/genetics , Female , Humans , Hyphae/isolation & purification , Immunocompromised Host , Lung Diseases, Fungal/drug therapy , Lung Diseases, Fungal/pathology , Nitriles/therapeutic use , Pyridines/therapeutic use , Switzerland , Tomography, X-Ray Computed , Treatment Outcome , Triazoles/therapeutic use , Zygomycosis/drug therapy , Zygomycosis/pathology
4.
Br J Radiol ; 88(1049): 20140687, 2015 May.
Article in English | MEDLINE | ID: mdl-25735428

ABSTRACT

OBJECTIVE: This study investigated the effectiveness of stereotactic body radiotherapy with helical TomoTherapy (T-SBRT) for treating medically inoperable primary and second-primary early stage non-small-cell lung neoplasm (SPLN) and evaluated whether the movement of organizing pneumonia (OP) within the irradiation field (IF) can be detected via analysis of radiological changes. METHODS: Patients (n = 16) treated for 1 year (2011-12) at our hospital by T-SBRT at a total dose of 60 Gy in five fractions were examined retrospectively. Outcome and toxicity were recorded and were separately described for SPLN. CT scans were reviewed by a single radiologist. RESULTS: Of the 16 patients, 5 (31.3%) had primary lung malignancies, 10 (62.5%) had SPLN, and 1 case (6.3%) had isolated mediastinal metastasis of lung neoplasm. Pathological evidence was obtained for 72.2% of all lesions. The median radiological follow-up was 11 months (10.5 months for SPLN). For all cases, the 6- and 12-month survival rates were 100% and 77.7% (100% and 71.4%, respectively, for SPLN), and the 6- and 12-month locoregional control rates were 100% in all cases. 2 (12.5%) of 16 patients developed grade 3 late transient radiation pneumonitis following steroid therapy and 1 (6.3%) presented asymptomatic infiltrates comparable to OP opacities. CONCLUSION: T-SBRT seems to be safe and effective. ADVANCES IN KNOWLEDGE: Mild OP is likely associated with radiation-induced anomalies in the IF, identification of migrating opacities can help discern relapse of radiation-induced opacities.


Subject(s)
Carcinoma, Non-Small-Cell Lung/diagnostic imaging , Carcinoma, Non-Small-Cell Lung/surgery , Lung Neoplasms/diagnostic imaging , Lung Neoplasms/surgery , Neoplasms, Second Primary/diagnostic imaging , Neoplasms, Second Primary/surgery , Radiation Injuries/diagnostic imaging , Radiation Injuries/etiology , Radiosurgery/adverse effects , Aged , Carcinoma, Non-Small-Cell Lung/pathology , Contrast Media , Female , Humans , Lung Neoplasms/pathology , Male , Neoplasm Staging , Neoplasms, Second Primary/pathology , Retrospective Studies , Tomography, Spiral Computed , Treatment Outcome
5.
Rev Med Suisse ; 10(435): 1337-42, 2014 Jun 18.
Article in French | MEDLINE | ID: mdl-25051596

ABSTRACT

Most cases of emphysema are managed conservatively. However, in severe symptomatic emphysema associated with hyperinflation, lung volume reduction (LVR) may be proposed to improve dyspnea, exercice capacity, pulmonary functions, walk distance and to decrease long-term mortality. LVR may be achieved either surgically (LVRS) or endoscopically (EVLR by valves or coils) according to specific clinical criteria. Currently, the optimal approach is discussed in a multidisciplinary setting. The latter permits a personalized evaluation the patient's clinical status and allows the best possible therapeutic intervention to be proposed to the patient.


Subject(s)
Dyspnea/etiology , Pneumonectomy/methods , Pulmonary Emphysema/surgery , Endoscopy/methods , Exercise Tolerance , Humans , Interdisciplinary Communication , Pulmonary Emphysema/physiopathology , Severity of Illness Index
6.
Rev Med Suisse ; 10(431): 1110-3, 2014 May 21.
Article in French | MEDLINE | ID: mdl-24941680

ABSTRACT

Locally advanced non-small-cell lung carcinoma (NSCLC) is a very heterogeous disease, the role of postoperative radiation therapy (PORT) in pN2 patients with completly resected NSCLC remains controversial. Although an improvment in local control has been described in several studies, the effect on survival has been contradictory or inconclusive. Retrospective evaluation suggest a positive effect of PORT in high risk patients with pN2 disease: RI-resected NSCLC, bulky and multilevel N2. However further evaluation of PORT in prospectively randomized studies in completely resected pN2 NSCLC is needed.


Subject(s)
Carcinoma, Non-Small-Cell Lung/radiotherapy , Lung Neoplasms/radiotherapy , Carcinoma, Non-Small-Cell Lung/surgery , Evidence-Based Medicine , Humans , Lung Neoplasms/surgery , Patient Selection , Postoperative Care , Radiotherapy, Adjuvant
7.
Infection ; 42(1): 153-4, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23728773

ABSTRACT

We report a patient suffering from cat-scratch disease limited to mediastinal lymphadenitis. Although rare, cat-scratch disease should be considered in the differential diagnosis of mediastinal lymphadenitis, especially when patients were exposed to cats.


Subject(s)
Cat-Scratch Disease/diagnosis , Cat-Scratch Disease/pathology , Lymphatic Diseases/diagnosis , Lymphatic Diseases/pathology , Mediastinal Diseases/diagnosis , Mediastinal Diseases/pathology , Female , Humans , Middle Aged , Positron-Emission Tomography , Radiography, Thoracic , Tomography, X-Ray Computed
8.
Rev Med Suisse ; 8(363): 2206-11, 2012 Nov 21.
Article in French | MEDLINE | ID: mdl-23240295

ABSTRACT

Lung cancer screening has been the focus of intense interest since the publication in 2011 of the NLST trial (National Lung Screening Trial) showing a mortality reduction in smokers undergoing 3-year screening by chest computed tomography. Although these data appear promising, many issues remain to be resolved, such as high rate of false positive cases, risk of overdiagnosis, optimal intervals between screens, duration of the screening process, feasibility, and cost. Structured screening programs appear crucial to guarantee patient information, technical quality, and multidisciplinary management. Despite these uncertainties, several guidelines already state that screening should be performed in patients at risk, whereas investigators stress that more data are needed. How should the primary care physician deal with individual patients requests? This review provides some clues on this complex issue.


Subject(s)
Lung Neoplasms/diagnosis , Mass Screening/methods , Tomography, X-Ray Computed/methods , False Positive Reactions , Humans , Lung Neoplasms/pathology , Physicians, Primary Care , Practice Guidelines as Topic , Risk Factors
9.
Sleep Med ; 13(6): 663-7, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22503005

ABSTRACT

OBJECTIVE: Sleep disordered breathing with central apnea or hypopnea frequently occurs at high altitude and is thought to be caused by a decrease in blood CO(2) level. The aim of this study was to assess the effects of added respiratory dead space on sleep disordered breathing. METHODS: Full polysomnographies were performed on 12 unacclimatized swiss mountaineers (11 males, 1 female, mean age 39 ± 12 y.o.) in Leh, Ladakh (3500 m). In random order, half of the night was spent with a 500 ml increase in dead space through a custom designed full face mask and the other half without it. RESULTS: Baseline data revealed two clearly distinct groups: one with severe sleep disordered breathing (n=5, AHI>30) and the other with moderate to no disordered breathing (n=7, AHI<30). DS markedly improved breathing in the first group (baseline vs DS): apnea hypopnea index (AHI) 70.3 ± 25.8 vs 29.4 ± 6.9 (p=0.013), oxygen desaturation index (ODI): 72.9 ± 24.1/h vs 42.5 ± 14.4 (p=0.031), whereas it had no significant effect in the second group or in the total population. Respiratory events were almost exclusively central apnea or hypopnea. Microarousal index, sleep efficiency, and sleep architecture remained unchanged with DS. A minor increase in mean PtcCO(2) (n=3) was observed with DS. CONCLUSION: A 500 ml increase in dead space through a fitted mask may improve nocturnal breathing in mountaineers with severe altitude-induced sleep disordered breathing.


Subject(s)
Altitude Sickness/therapy , Mountaineering/physiology , Respiratory Dead Space/physiology , Respiratory Therapy/methods , Sleep Apnea Syndromes/therapy , Adult , Altitude , Altitude Sickness/blood , Altitude Sickness/physiopathology , Carbon Dioxide/blood , Electroencephalography , Female , Humans , Male , Masks , Middle Aged , Polysomnography , Sleep Apnea Syndromes/blood , Sleep Apnea Syndromes/physiopathology , Treatment Outcome
10.
Rev Med Suisse ; 3(133): 2584-6, 2588-9, 2007 Nov 14.
Article in French | MEDLINE | ID: mdl-18078187

ABSTRACT

Optimization of patients flow can decrease the overcrowding of the emergency department (ED) and improve the level of patient's satisfaction. The prospective analysis of 502 consecutive admissions at the Nyon regional hospital's ED shows a mean length of stay (LOS) of 145 minutes, for a majority of low-severity cases admitted during working hours. A significant LOS variability reveals transient episodes of overcrowding, which lead to an increase in the LOS of mainly ambulatory patients. Our analysis shows that both the ED's structure and the medical organization create a gap between ED performance as care provider and the patients' expectations, and suggests that a separation of low-versus high-complexity cases is necessary. Patients' flow analysis can detect ED overcrowding and may help find the appropriate solutions to reduce it.


Subject(s)
Emergency Service, Hospital/organization & administration , Hospitals, District/organization & administration , Primary Health Care/organization & administration , Adult , Ambulatory Care/organization & administration , Ambulatory Care/statistics & numerical data , Emergency Service, Hospital/statistics & numerical data , Health Services Accessibility/organization & administration , Health Services Accessibility/statistics & numerical data , Hospitals, District/statistics & numerical data , Humans , Length of Stay/statistics & numerical data , Middle Aged , Patient Admission/statistics & numerical data , Patient Satisfaction , Primary Health Care/statistics & numerical data , Prospective Studies , Switzerland , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...